[Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)] (Q85015479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

[Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Antoni Torres

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Javier Aspa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Alberto Capelastegui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Cristina Prat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Felipe Rodríguez de Castro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Sociedad Española de Neumología y Cirugía Torácica

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

15 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

Archivos de Bronconeumologia

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

543-558

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Epidemiology of community-acquired pneumonia in adults: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Risk factors for community-acquired pneumonia in adults: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Increasing hospital admissions for pneumonia, England

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

The outcome of community acquired pneumonia treated on the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Mixed community-acquired pneumonia in hospitalised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Health Care–Associated Pneumonia Requiring Hospital Admission

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Confidential inquiry into quality of care before admission to intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Severe Community‐Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Development and validation of a clinical prediction rule for severe community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Validation of a predictive rule for the management of community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Usefulness of pneumococcal antigen detection in pleural fluid samples by immunochromatographic assay for diagnosis of pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Detection of Streptococcus pneumoniae Antigen by a Rapid Immunochromatographic Assay in Urine Samples

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

PCR detection of Streptococcus pneumoniae DNA in serum samples for pneumococcal pneumonia diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Procalcitonin and neopterin correlation with aetiology and severity of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Guidelines for the management of adult lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Normativas para el diagnóstico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Macrolide resistance in bacteremic pneumococcal disease: implications for patient management.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Clinical practice. Management of community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Treatment failure in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

C-reactive protein is an independent predictor of severity in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Markers of treatment failure in hospitalised community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Stability in community-acquired pneumonia: one step forward with markers?

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Imaging of pneumonia: trends and algorithms

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Pneumococcal vaccination of elderly adults: new paradigms for protection.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Pneumococcal vaccine--direct and indirect ("herd") effects

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

New evidence of risk factors for community-acquired pneumonia: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Clinical study of an outbreak of Legionnaire's disease in Alcoy, Southeastern Spain

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2811%2960008-6

7 January 2021

10.1016/S1579-2129(11)60008-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20832928%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference